Letrozol Combix (Letrozole)

Letrozole blocks the aromatase enzyme, preventing the conversion of androgens into estrogen. By reducing circulating estrogen, the drug deprives estrogen‑dependent breast cancer cells of a key growth signal, thereby inhibiting tumor progression.

The specific dose of Letrozol Combix is determined by the prescribing physician based on the patient’s clinical condition, treatment goals, and tolerance. Dosage adjustments are made according to medical judgment and monitoring results.

Letrozole is classified as contraindicated in pregnancy because it can affect fetal development. Its safety during breastfeeding has not been established, and breastfeeding is generally not recommended while taking this medication.

To order Letrozol Combix, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies institutional credentials, and then provides pricing, availability, shipping details, and necessary import documentation.

Letrozol Combix, as an aromatase inhibitor, lowers estrogen production, whereas drugs like tamoxifen block estrogen receptors. In postmenopausal patients, aromatase inhibitors often provide superior disease control, but choice depends on individual patient factors, side‑effect profiles, and physician preference.

Letrozol Combix tablets should be stored at ambient temperature, preferably below 25 °C. Keep them in the original blister pack, protect from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Letrozol Combix is taken orally, usually once daily, with or without food. The tablet should be swallowed whole with a glass of water and not chewed or crushed, unless otherwise directed by a healthcare professional.

Serious risks include severe liver injury, bone fractures due to decreased estrogen, and thromboembolic events such as deep‑vein thrombosis or pulmonary embolism. Patients should be monitored regularly for signs of these conditions and report any concerning symptoms promptly.

Letrozol Combix should not be used by pregnant women, women of childbearing potential who are not using effective contraception, or patients with known hypersensitivity to letrozole or any tablet excipients. Caution is also advised in individuals with severe liver disease or uncontrolled osteoporosis.